PAR paradigm biopharmaceuticals limited..

A side by side comparison..., page-7

  1. 1,642 Posts.
    lightbulb Created with Sketch. 329
    I guess the hopium posts are not getting anyone to buy shares atm. As previously posted, i reckon we all know the data is good. I dont think that is the problem though. Still part time ceo ripping a mill per annum cash out of us in addition to his chair role. No accountability, no proper governance and No financial modelling at all presented to investors. massive quarterly spends and we havent really started the main game yet…heck we still havent locked in dosage. Probable Cap raise overhanging us. I think these are our issues, not the data.

    hopium is great but i reckon it would be nice to see some commentary around the real issues facing par success.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
43.0¢
Change
-0.035(7.53%)
Mkt cap ! $170.8M
Open High Low Value Volume
47.0¢ 47.5¢ 42.0¢ $676.1K 1.519M

Buyers (Bids)

No. Vol. Price($)
2 16161 43.0¢
 

Sellers (Offers)

Price($) Vol. No.
44.5¢ 19584 1
View Market Depth
Last trade - 16.10pm 07/07/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.